Eli Lilly Canada Inc.
Lilly is committed to providing answers that matter in medicine, life sciences and health care. As a leading inovation-driven corporation, Lilly is developing a growing portfolio of products by applying the latest research from its own worldwide laboratories, by collaborating with eminent scientific organizations, by making use of the most up-to-date technological tools and by providing exceptional service to its customers.
Company Details
Year Established:
1938
Number of Employees:
850
Company Information
David Ricks
Title:
General Manager
Telephone:
(416) 694-3221
Fax:
(416) 694-0487
Terry Mccool
Title:
Vice President
Area of Responsibility:
Government Relations
Telephone:
(416) 694-3221
Fax:
(416) 693-3604
Products
Zyprexa (olanzapine)
Humalog (insulin Lispro Injection [rdna Origin])
Humalog (insulin lispro injection [rDNA origin]) is a mealtime insulin that offers control, flexibility and convenience. Its unique rapid action mimics the bodys own insulin after meals.
Gemzar (gemcitabine)
Gemzar (gemcitabine) belongs to a class of drugs known as antimetabolites. It is approved as a single agent for the treatment of advanced pancreatic cancer; as a single agent or in combination with cisplatin for advanced non-small-cell lung cancer; in combination with cisplatin for the treatment of metastatic bladder cancer; and in combination with paclitaxel for the treatment of metastaic breast cancer.
Reopro (abciximab)
ReoPro (abciximab) is a medication in a class of potent anti-platelet drugs known as glycoprotein IIb/IIIa inhibitors. These compounds prevent clots from forming in the arteries and the treatment
of coronary artery blockage and prevention of restenosis.
Evista (raloxifene Hydrochloride)
Evista is a non-hormonal osteoporosis therapy called a Selective Estrogen Receptor Modulator (SERM) and is approved for the prevention and treatment of osteoporosis.
Actos (pioglitazone Hydrochloride)
Actos (pioglitazone hydrochloride) is an oral treatment in a member of a class of drugs called thiazolidinediones (TZDs) that target one of the two underlying causes of type 2 diabetes: insulin resistance. It is approved as a monotherapy; and for use in combination with sulfonylureas or metformin to improve glycemic control when diet and exercise plus a single agent have failed.
Alimta (pemetrexed)
Alimta (pemetrexed) is a multi-targeted anti-cancer drug for use with cisplatin, a standard chemotherapy agent, in the treatment of malignant pleural mesothelioma (MPM) in patients whose disease is either unresectable, unable to be surgically removed, or who are not candidates for curative surgery. MPM is a cancer of the lining of the lungs often associated with asbestos exposure.
Cialis (tadalafil)
Cialis (tadalafil) is an oral medication for the treatment of erectile dysfunction. It belongs to the class of drugs known as phosphodiesterase type 5 (PDE5) inhibitors.
Forteo (teriparatide [rdna Origin] Injection)
Forteo (teriparatide [rDNA origin] injection) is a medication in a new class of osteoporosis treatments called bone formation agents. It is indicated for the treatment of postmenopausal women with severe osteoporosis who are at high risk of fracture or who have failed or are intolerant to previous osteoporosis therapy. In addition, it is indicated to increase bone mass in men with primary or hypogonadal (low testosterone) severe osteoporosis who have failed or are intolerant to previous osteoporosis therapy.
Humatrope (somatropin [rdna Origin] For Injection)
Humatrope (somatropin [rDNA origin] for injection) is a biosynthetic growth hormone with the same chemical structure as the growth hormone produced by the human pituitary gland. Humatrope is approved for the treatment of growth hormone deficiency in children; for adult replacement therapy; and for treatment in girls with short stature due to Turner Syndrome.
Humulin (insulin, Human Biosynthetic)
Humulin (insulin, human biosynthetic) family of insulins includes Humulin N, Humulin R and Humulin 30/70. The different formulations vary in the onset and duration of action. A synthetic insulin that is identical in chemical structure to the insulin naturally produced by the pancreas, Humulin is made by a chemical process called recombinant DNA technology.
Strattera (atomoxetine)
Strattera (atomoxetine), a non-stimulant, is approved for the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) in children six years of age and over, adolescents and adults.
Xigris (drotrecogin Alfa [activated])
Xigris (drotrecogin alfa [activated]) is approved for the reduction of mortality in adult patients with severe sepsis who have a high risk of death, when added to current best practice.
Services